CN Stock MarketDetailed Quotes
002437 Harbin Gloria Pharmaceuticals
- 2.91
- 0.000.00%
Noon Break Dec 12 11:30 CST
6.63BMarket Cap83.14P/E (TTM)
2.98High2.85Low1.07MlotVolume2.88Open2.91Pre Close312.71MTurnover4.88%Turnover Ratio54.91P/E (Static)2.28BShares2.9952wk High3.51P/B6.37BFloat Cap1.6652wk Low3.20Limit Up2.19BShs Float14.95Historical High2.62Limit Down4.47%Amplitude1.66Historical Low--Dividend TTM2.92Avg Price483.74KlotAsk--Div YieldTTM100Lot Size583.87KlotBid
Harbin Gloria Pharmaceuticals Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -8.74%2.06B | -13.41%1.34B | -8.55%679.5M | -15.33%2.87B | -14.25%2.25B | -8.85%1.55B | -11.17%743.01M | -4.72%3.39B | -0.34%2.63B | -0.11%1.7B |
| Cash received relating to other operating activities | -10.63%128.99M | 88.96%102.26M | 166.90%72.22M | -3.61%207.86M | 19.82%144.33M | 7.28%54.11M | -69.59%27.06M | 18.27%215.65M | -24.68%120.46M | -49.94%50.44M |
| Cash inflows from operating activities | -8.85%2.18B | -9.96%1.44B | -2.38%751.72M | -14.63%3.08B | -12.76%2.4B | -8.39%1.6B | -16.79%770.07M | -3.60%3.61B | -1.73%2.75B | -2.90%1.75B |
| Goods services cash paid | 6.96%314.67M | 12.28%218.75M | 0.04%98.68M | -27.13%415.27M | -36.09%294.18M | -34.51%194.83M | -38.79%98.64M | -16.13%569.86M | -9.87%460.32M | -10.80%297.48M |
| Staff behalf paid | -14.79%277.9M | -13.22%193.01M | -10.87%102.59M | -18.18%431.97M | -20.80%326.14M | -24.93%222.42M | -28.50%115.1M | -10.81%527.94M | -9.65%411.79M | -10.22%296.3M |
| All taxes paid | -8.33%193.69M | -10.72%130.91M | -12.74%65.03M | -7.62%265.66M | 2.32%211.28M | -4.87%146.63M | 4.37%74.53M | 2.50%287.58M | 6.51%206.5M | 25.40%154.14M |
| Cash paid relating to other operating activities | -12.73%1.1B | -16.47%699.18M | -18.07%326.18M | -13.66%1.69B | -10.17%1.26B | -1.60%837.01M | -16.20%398.1M | 2.30%1.96B | -1.96%1.4B | -2.95%850.65M |
| Cash outflows from operating activities | -9.83%1.88B | -11.35%1.24B | -13.68%592.48M | -16.14%2.81B | -15.71%2.09B | -12.37%1.4B | -20.98%686.37M | -3.53%3.35B | -4.24%2.48B | -3.87%1.6B |
| Net cash flows from operating activities | -2.16%300.5M | -0.29%201.89M | 90.25%159.24M | 4.80%274.18M | 14.55%307.14M | 33.58%202.47M | 47.30%83.7M | -4.58%261.62M | 29.72%268.12M | 8.77%151.57M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -99.08%4.5M | -99.12%3M | -97.34%1.5M | 14.12%508.2M | 14.72%486.7M | -18.84%342.8M | -81.21%56.38M | -71.33%445.32M | -64.21%424.25M | -50.82%422.4M |
| Cash received from returns on investments | 35.21%8.86M | 162.43%5.5M | ---- | -59.17%6.61M | -53.18%6.55M | -78.78%2.1M | -98.91%31.64K | 163.27%16.2M | 84.90%14M | 164.14%9.88M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 3,795.92%18.05M | 4,424.87%13.64M | 2,285.01%7M | -65.93%13.65M | -98.36%463.33K | -97.50%301.45K | -97.07%293.5K | 1,216.61%40.05M | 975.42%28.2M | 997.40%12.05M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | -74.55%732.07K | -74.55%732.07K | -65.82%732.07K | -65.20%489.7K | -96.16%2.88M | 214.44%2.88M | 134.14%2.14M |
| Cash inflows from investing activities | -93.65%31.41M | -93.60%22.14M | -85.14%8.5M | 4.91%529.19M | 5.35%494.45M | -22.52%345.93M | -81.81%57.2M | -69.19%504.45M | -60.77%469.33M | -48.36%446.47M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 83.05%33.75M | 76.50%23.56M | 79.48%13.1M | -10.27%29.62M | -4.76%18.44M | 2.18%13.35M | -19.48%7.3M | -4.34%33.01M | -12.81%19.36M | 10.15%13.06M |
| Cash paid to acquire investments | ---- | ---- | -98.52%152.51K | -41.73%405.19M | -46.19%368.25M | -53.36%290.3M | -97.56%10.3M | -54.30%695.32M | -46.44%684.3M | -23.49%622.4M |
| Net cash paid to acquire subsidiaries and other business units | --2.51M | --428.88K | ---- | ---- | ---- | ---- | --3M | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | --11.45M | ---- | ---- | ---- |
| Cash outflows from investing activities | -90.62%36.26M | -92.10%23.99M | -58.64%13.26M | -40.30%434.81M | -45.05%386.69M | -52.22%303.65M | -92.57%32.05M | -53.19%728.33M | -45.87%703.66M | -23.01%635.46M |
| Net cash flows from investing activities | -104.50%-4.85M | -104.36%-1.84M | -118.92%-4.76M | 142.16%94.38M | 145.99%107.76M | 122.37%42.28M | 121.49%25.15M | -375.50%-223.88M | -126.47%-234.34M | -582.12%-188.99M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --103.21M | --90.49M | --90.49M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -89.50%115M | -89.50%115M | -96.40%25M | -29.62%1.1B | -29.62%1.1B | -29.62%1.1B | -15.23%695.2M | -20.12%1.56B | -20.12%1.56B | -20.12%1.56B |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -40.08%104.92M | -51.52%104.92M | -51.52%104.92M |
| Cash inflows from financing activities | -80.07%218.21M | -81.24%205.49M | -83.39%115.49M | -34.06%1.1B | -34.06%1.1B | -34.06%1.1B | -24.85%695.2M | -21.77%1.66B | -23.26%1.66B | -23.26%1.66B |
| Borrowing repayment | -57.36%745.36M | -56.41%674.86M | -64.63%274.9M | 12.92%1.87B | 12.35%1.75B | -0.50%1.55B | -5.25%777.09M | -0.81%1.66B | -6.30%1.56B | -5.73%1.56B |
| Dividend interest payment | -74.43%9.11M | -68.52%8.41M | -62.77%5.58M | -42.40%43.81M | -39.59%35.61M | -33.50%26.72M | -33.39%14.99M | 0.83%76.06M | 15.01%58.95M | 10.35%40.19M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 62.22%7.3M | 62.22%7.3M | 215.00%6.3M |
| Cash payments relating to other financing activities | -94.64%1.19M | ---- | ---- | -51.43%67.22M | -82.42%22.22M | -80.91%22.22M | -96.03%4.37M | 925.75%138.39M | 836.81%126.39M | 2.56%116.39M |
| Cash outflows from financing activities | -58.16%755.66M | -57.22%683.27M | -64.78%280.48M | 5.92%1.98B | 3.71%1.81B | -6.74%1.6B | -16.40%796.45M | 6.36%1.87B | 0.93%1.74B | -4.88%1.71B |
| Net cash flows from financing activities | 24.39%-537.44M | 4.81%-477.78M | -62.94%-164.99M | -318.33%-889.16M | -783.85%-710.83M | -871.62%-501.94M | -265.23%-101.26M | -158.78%-212.55M | -118.32%-80.42M | -114.20%-51.66M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -136.60%-674.43K | -82.19%390K | 114.01%108.16K | -91.72%987.34K | -86.32%1.84M | -67.33%2.19M | -45.34%-771.95K | 857.47%11.92M | 3,901.14%13.47M | 5,264.91%6.7M |
| Net increase in cash and cash equivalents | 17.55%-242.47M | -8.77%-277.35M | -252.54%-10.4M | -219.00%-519.62M | -786.45%-294.08M | -209.57%-254.99M | 107.71%6.82M | -122.77%-162.89M | -106.12%-33.18M | -115.19%-82.37M |
| Add:Begin period cash and cash equivalents | -42.22%711M | -42.22%711M | -42.22%711M | -11.69%1.23B | -11.69%1.23B | -11.69%1.23B | -11.69%1.23B | 105.52%1.39B | 105.52%1.39B | 105.52%1.39B |
| End period cash equivalent | -49.97%468.54M | -55.55%433.66M | -43.38%700.61M | -42.22%711M | -31.15%936.54M | -25.59%975.63M | -5.18%1.24B | -11.69%1.23B | 11.45%1.36B | 7.45%1.31B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
